Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 16, 2016 - Issue 3
Submit an article Journal homepage
686
Views
32
CrossRef citations to date
0
Altmetric
Reviews

Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium

Davide SeripaGeriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo, Foggia, ItalyCorrespondence[email protected] [email protected]
,
Vincenzo SolfrizziGeriatric Medicine-Memory Unit and Rare Disease Centre, University of Bari Aldo Moro, Bari, Italy
,
Bruno P. ImbimboResearch & Development Department, Chiesi Farmaceutici, Parma, Italy
,
Antonio DanieleInstitute of Neurology, Catholic University of Sacred Heart, Rome, Italy
,
Andrea SantamatoPhysical Medicine and Rehabilitation Section, ‘OORR’ Hospital, University of Foggia, Foggia, Italy
,
Madia LozuponeNeurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy
,
Giovanni ZulianiDepartment of Medical Science, Section of Internal and Cardiopulmonary Medicine, University of Ferrara
,
Antonio GrecoGeriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo, Foggia, Italy
,
Giancarlo LogroscinoNeurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy;Department of Clinical Research in Neurology, University of Bari Aldo Moro, ‘Pia Fondazione Cardinale G. Panico’, Tricase, Lecce, Italy
&
Francesco PanzaGeriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo, Foggia, Italy;Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy;Department of Clinical Research in Neurology, University of Bari Aldo Moro, ‘Pia Fondazione Cardinale G. Panico’, Tricase, Lecce, ItalyCorrespondence[email protected] [email protected]
 show all
Pages 259-277 | Received 06 Oct 2015, Accepted 06 Jan 2016, Published online: 26 Feb 2016

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Madia Lozupone, Vittorio Dibello, Rodolfo Sardone, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Ilaria Bortone, Roberta Stallone, Mario Altamura, Antonello Bellomo, Antonio Daniele, Vincenzo Solfrizzi & Francesco Panza. (2023) The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies. Expert Opinion on Drug Discovery 18:5, pages 515-526.
Read now
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Juan F. González, Andrés R. Alcántara, Antonio L. Doadrio & Jose María Sánchez-Montero. (2019) Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches. Expert Opinion on Drug Discovery 14:9, pages 879-891.
Read now
Giancarlo Logroscino, Bruno P. Imbimbo, Madia Lozupone, Rodolfo Sardone, Rosa Capozzo, Petronilla Battista, Chiara Zecca, Vittorio Dibello, Gianluigi Giannelli, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa & Francesco Panza. (2019) Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs. Expert Opinion on Pharmacotherapy 20:9, pages 1091-1107.
Read now
Francesco Panza, Bruno P. Imbimbo, Madia Lozupone, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Antonio Daniele & Carlo Colosimo. (2019) Disease-modifying therapies for tauopathies: agents in the pipeline. Expert Review of Neurotherapeutics 19:5, pages 397-408.
Read now
Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2018) The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opinion on Biological Therapy 18:1, pages 25-35.
Read now
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza, Paola Bisceglia, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2016) Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients. Expert Opinion on Emerging Drugs 21:4, pages 377-391.
Read now

Articles from other publishers (25)

Yong Peng, Hong Jin, Ya-hui Xue, Quan Chen, Shun-yu Yao, Miao-qiao Du & Shu Liu. (2023) Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks. Frontiers in Aging Neuroscience 15.
Crossref
Bin Wang, Xiaofang Zhong, Lauren Fields, Haiyan Lu, Zexin Zhu & Lingjun Li. (2023) Structural Proteomic Profiling of Cerebrospinal Fluids to Reveal Novel Conformational Biomarkers for Alzheimer’s Disease. Journal of the American Society for Mass Spectrometry 34:3, pages 459-471.
Crossref
Ji Hye Yoon, JooHyun Hwang, Sung Un Son, Junhyuk Choi, Seung-Won You, Hyunwoo Park, Seung-Yun Cha & Sungho Maeng. (2023) How Can Insulin Resistance Cause Alzheimer’s Disease?. International Journal of Molecular Sciences 24:4, pages 3506.
Crossref
Zhuo Jun Shen, Yun Bo Fu, Jin Ling Hou, Lu Ning Lin, Xiao Yan Wang, Chang Yu Li & Yuan Xiao Yang. (2022) Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease. Chinese Medicine 17:1.
Crossref
Bofan Li, Nannan Wang, Jie Zheng, Houjuan Zhu, Sheng Wang, Enyi Ye & Zibiao Li. 2022. Sustainable Nanotechnology. Sustainable Nanotechnology 33 64 .
Gesine Respondek, Lea Krey, Meret Huber, Henning Pflugrad, Florian Wegner & Günter U. Höglinger. (2021) Neuroprotektive Therapien bei TauopathienNeuroprotective treatment of tauopathies. Der Nervenarzt 92:12, pages 1227-1238.
Crossref
Jiayi Song, Xuehan Yang, Ming Zhang, Chunyan Wang & Li Chen. (2021) Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer’s Disease. Journal of Alzheimer's Disease 84:2, pages 557-578.
Crossref
Dan Wang, Xianlong Huang, Lu Yan, Luoqi Zhou, Chang Yan, Jinhu Wu, Zhengding Su & Yongqi Huang. (2021) The Structure Biology of Tau and Clue for Aggregation Inhibitor Design. The Protein Journal 40:5, pages 656-668.
Crossref
Sruti Rayaprolu, Lenora Higginbotham, Pritha Bagchi, Caroline M. Watson, Tian Zhang, Allan I. Levey, Srikant Rangaraju & Nicholas T. Seyfried. (2020) Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau. Neuropsychopharmacology 46:1, pages 98-115.
Crossref
Francesco Panza, Madia Lozupone, Davide Seripa, Antonio Daniele, Mark Watling, Gianluigi Giannelli & Bruno P. Imbimbo. (2020) Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nature Reviews Neurology 16:4, pages 213-228.
Crossref
Richard L. Jayaraj, Sheikh Azimullah & Rami Beiram. (2020) Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators. Saudi Journal of Biological Sciences 27:2, pages 736-750.
Crossref
Xiaojun Cai, Kai Zhang, Xue Xie, Xiandi Zhu, Jin Feng, Zhiming Jin, Hong Zhang, Mei Tian & Hangrong Chen. (2020) Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 231, pages 119678.
Crossref
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence J. O’Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman & Mohd. Farooq Shaikh. (2019) Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease. ACS Chemical Neuroscience 10:10, pages 4199-4212.
Crossref
Klaus Fließbach, Cornelia McCormick, Barbara Kaulen & Anja Schneider. (2019) Anti-Tau-Therapien – was können wir erwarten?Anti-tau therapies—what can be expected?. Der Nervenarzt 90:9, pages 891-897.
Crossref
Yu Chen, Amy K.Y. Fu & Nancy Y. Ip. (2019) Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies. Pharmacology & Therapeutics 195, pages 186-198.
Crossref
Lei Zhao, Xiaoqin Cheng & Chunjiu Zhong. (2018) Implications of Successful Symptomatic Treatment in Parkinson’s Disease for Therapeutic Strategies of Alzheimer’s Disease. ACS Chemical Neuroscience 10:2, pages 922-930.
Crossref
Maria Berrocal, Isaac Corbacho, Carlos Gutierrez-Merino & Ana M. Mata. (2018) Methylene blue activates the PMCA activity and cross-interacts with amyloid β-peptide, blocking Aβ-mediated PMCA inhibition. Neuropharmacology 139, pages 163-172.
Crossref
Talita P.C. Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, Carlos Requena, Victor Sebastian-Perez, Willian O. Castillo, Natalia C.S. Moreira, Concepción Pérez, Elza T. Sakamoto-Hojo, Catarina S. Takahashi, Jesús Jiménez-Barbero, F. Javier Cañada, Nuria E. Campillo, Ana Martinez & Ivone Carvalho. (2017) From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry 139, pages 773-791.
Crossref
Massimiliano Buoli, Marta Serati, Alice Caldiroli, Daniela Galimberti, Elio Scarpini & Alfredo Carlo Altamura. (2017) Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review. Journal of Geriatric Psychiatry and Neurology 30:3, pages 162-169.
Crossref
Hongwu Liu, Jian Yang, Letian Wang, Yungen Xu, Siyuan Zhang, Jie Lv, Chongzhao Ran & Yuyan Li. (2017) Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes. Future Medicinal Chemistry 9:2, pages 179-198.
Crossref
Zhidong Liu, Aihua Zhang, Hui Sun, Ying Han, Ling Kong & Xijun Wang. (2017) Two decades of new drug discovery and development for Alzheimer's disease. RSC Advances 7:10, pages 6046-6058.
Crossref
Akhlaq A. Farooqui. 2017. Neurochemical Aspects of Alzheimer's Disease. Neurochemical Aspects of Alzheimer's Disease 331 359 .
S. Quraishe, C.M. Cowan & A. Mudher. 2017. Neuroprotection in Alzheimer's Disease. Neuroprotection in Alzheimer's Disease 73 96 .
Rizwanul Haque & Aamir Nazir. 2017. Drug Design: Principles and Applications. Drug Design: Principles and Applications 9 29 .
Miguel Medina, Félix Hernández & Jesús Avila. (2016) New Features about Tau Function and Dysfunction. Biomolecules 6:2, pages 21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.